Reference | Year | Indication | Aetiology | Delivery method | Efficacy |
Delacoste63 | 1959 | Refractory coughs | NA | Inhalation | 100% |
Hoeflmayr et al64 | 1962 | Bronchitis | Streptococci (2/3); Staphylococci (1/3) | Inhalation | 90% |
Garsevanishvili65 | 1974 | Pneumonia | Staphylococci, streptococci and enterococci were targeted | Inhalation | N/A |
Ioseliani et al66 | 1980 | Lung infections | Staphylococci and/or others | Inhalation, bronchoscopy | >90% |
Meladze et al67 | 1982 | Parenchyma and pleura infections | Staphylococcus | Inhalation, topical, parenteral | >90% (223) |
Kvachadze et al68 | 2011 | Cystic fibrosis-associated infections | Staphylococcus and Pseudomonas | Inhalation | Improvement |
This table was adapted from Abedon et al. These studies that have been cited may be in languages other than English and therefore are obtained from a summarised review article that has been published in English.69